Link Pharma Chem Ltd Share Price

44.24
(-2.75%)
Jul 23, 2024|03:43:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open44.5
  • Day's High44.5
  • 52 Wk High55.71
  • Prev. Close45.49
  • Day's Low42.33
  • 52 Wk Low39.1
  • Turnover (lac)0.28
  • P/E0
  • Face Value10
  • Book Value30.87
  • EPS0
  • Mkt. Cap (Cr.)19.64
  • Div. Yield0
No Records Found

Link Pharma Chem Ltd KEY RATIOS

Sector

Chemicals

Open

44.5

Prev. Close

45.49

Turnover(Lac.)

0.28

Day's High

44.5

Day's Low

42.33

52 Week's High

55.71

52 Week's Low

39.1

Book Value

30.87

Face Value

10

Mkt Cap (₹ Cr.)

19.64

P/E

0

EPS

0

Divi. Yield

0

Link Pharma Chem Ltd Corporate Action

29 Aug 2023

12:00 AM

BookCloser

arrow

29 Aug 2023

12:00 AM

AGM

Announcement Date: 29 Aug, 2023

arrow

21 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Link Pharma Chem Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Link Pharma Chem Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:25 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 51.48%

Foreign: 0.00%

Indian: 51.48%

Non-Promoter- 0.01%

Institutions: 0.01%

Non-Institutions: 48.49%

Custodian: 0.00%

Share Price

Link Pharma Chem Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

4.44

4.44

4.44

4.44

Preference Capital

0

0

0

0

Reserves

10.6

10.03

8.12

6.99

Net Worth

15.04

14.47

12.56

11.43

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

53.56

34.81

25.47

24.5

yoy growth (%)

53.85

36.67

3.96

4.11

Raw materials

-36.43

-17.77

-9.91

-11.32

As % of sales

68.01

51.06

38.92

46.23

Employee costs

-5.77

-5.62

-4.98

-4.71

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

2.62

1.67

1.44

0.93

Depreciation

-0.92

-0.87

-0.92

-0.89

Tax paid

-0.73

-0.59

-0.49

-0.27

Working capital

0.08

0.34

2.78

0.56

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

53.85

36.67

3.96

4.11

Op profit growth

19

13.05

30.27

-27.32

EBIT growth

45.01

17.55

36.99

-33.75

Net profit growth

73.44

14.21

44.32

-42

View Ratios

No Record found

Link Pharma Chem Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

3,149

88.931,60,161.08354.320.512,588.88163.92

SRF Ltd

SRF

2,367.9

51.2370,190.43437.10.312,857.61353.96

Linde India Ltd

LINDEINDIA

8,099.95

163.7769,076.37104.330.15630.07402.73

Deepak Nitrite Ltd

DEEPAKNTR

2,850.65

110.0638,880.88115.680.26671.15216.61

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,248.4

85.2235,683.6786.010.091,043.2539.16

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Link Pharma Chem Ltd

Management

Register Office

Registrar Office

Chairman & Wholetime Director

S G Thakur

Managing Director

Rishikesh S.Thakur

Independent Director

S B Dhatrak

Independent Director

Devang U Shah

Independent Director

Rachna Ghai

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Link Pharma Chem Ltd (LPCL) is a mid-size leading chemical manufacturing company, incorporated in the year 1986. The Company operate in the small-scale sector to manufacture 300 tpa of thionil chloride(TC). The Company increased its capacity to 1500 tpa in 1989 to meet the growing demand. It undertook a further expansion in 1993 with assistance from SIDBI to increase capacity to 2100 tpa, which was completed in 1994.The Company is engaged in manufacturing and exporting multi range intermediates for pharmaceutical, agro industries and specialty chemicals. It is engaged in custom synthesis / contract manufacturing for multistage synthesis for small, medium, large companies as well. The Companys strength lies in carrying out very critical corrosive reactions involving chemicals like Chlorine, Oleum, Chlorosulphonic Acid, Sulphuric Acid, Sulphur Chlorides etc. and also to control the laid down environmental needs. It is equipped with adequate glass lined & S. S. reactor capacities aided by all sorts of utilities and supporting accessories. The services offered are contract manufacturing facilities; development of multi step pathways for organic synthesis and refinement and optimization of existing synthetic methods. A partnership firm (cap.: 1080 tpa) manufacturing chlorinated paraffin (CP) was merged with LPCL in Apr.94. This formed the present unit, Link Pharma Chem. It modernized and expanded its TC capacity to 3300 tpa, expanded its product range to include CP 70 (450 tpa), a
Read More

Company FAQs

What is the Link Pharma Chem Ltd share price today?

Down Arrow

The Link Pharma Chem Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹44.24 today.

What is the Market Cap of Link Pharma Chem Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Link Pharma Chem Ltd is ₹19.64 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Link Pharma Chem Ltd?

Down Arrow

The PE and PB ratios of Link Pharma Chem Ltd is 0 and 1.47 as of 23 Jul ‘24

What is the 52 Week High and Low of Link Pharma Chem Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Link Pharma Chem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Link Pharma Chem Ltd is ₹39.1 and ₹55.71 as of 23 Jul ‘24

What is the CAGR of Link Pharma Chem Ltd?

Down Arrow

Link Pharma Chem Ltd's CAGR for 5 Years at 32.35%, 3 Years at 6.98%, 1 Year at -2.94%, 6 Month at 0.86%, 3 Month at 0.42% and 1 Month at 1.72%.

What is the shareholding pattern of Link Pharma Chem Ltd?

Down Arrow

The shareholding pattern of Link Pharma Chem Ltd is as follows:
Promoters - 51.49 %
Institutions - 0.02 %
Public - 48.49 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.